|Last Price$9.22||Day Change (%)0.22%|
|Open Price$9.22||Day Change ($)0.02|
|Day Range9.22–9.22||52-Week Range9.20–9.61|
As of Thu 07/30/2015 | USD
Favorable conditions are in place for merger-arbitrage ETFs, including increasing M&A activity and the likelihood of higher interest rates.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
We'd prefer a pack of gum to these businesses.
Three ways to separate long-term winners from stocks that fizzle.